Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
Authors:
- 1 November 1995
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 96 (5) , 571-579
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Guidelines on the management of asthma. Statement by the British Thoracic Society, the Brit. Paediatric Association, the Research Unit of the Royal College of Physicians of London, the King's Fund Centre, the National Asthma Campaign, the Royal College of General Practitioners, the General Practitioners in Asthma Group, the Brit. Assoc. of Accident and Emergency Medicine, and the Brit. Paediatric Respiratory Group.Thorax, 1993
- Effects of dose and dosing schedule of inhaled budesonide on bone turnoverJournal of Allergy and Clinical Immunology, 1991
- Inhaled budesonide and behavioural disturbancesThe Lancet, 1991
- Inhaled corticosteroids, bone formation, and osteocalcinThe Lancet, 1991
- Clinical Use of Bone DensitometryNew England Journal of Medicine, 1991
- Beclomethasone inhalation decreases serum osteocalcin concentrations.BMJ, 1991
- Bone turnover during high dose inhaled corticosteroid treatment.Thorax, 1991
- Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects.Thorax, 1987
- Corticosteroids and bone mass in asthma.BMJ, 1987
- Steroid-Induced Fractures and Bone Loss in Patients with AsthmaNew England Journal of Medicine, 1983